Taubert D - Search Results

1

Esomeprazole but not pantoprazole is associated with lower plasma concentrations of clopidogrel's active metabolite.

Harmsze AM, van Werkum JW, Taubert D, Hackeng CM, Deneer VH. Harmsze AM, et al. Among authors: taubert d. Ann Pharmacother. 2011 Apr;45(4):542-3. doi: 10.1345/aph.1P425. Epub 2011 Apr 12. Ann Pharmacother. 2011. PMID: 21487078 No abstract available.

2

Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel.

Bouman HJ, Parlak E, van Werkum JW, Breet NJ, ten Cate H, Hackeng CM, ten Berg JM, Taubert D. Bouman HJ, et al. Among authors: taubert d. J Thromb Haemost. 2010 Mar;8(3):482-8. doi: 10.1111/j.1538-7836.2009.03733.x. Epub 2009 Dec 21. J Thromb Haemost. 2010. PMID: 20040042 Free article.

3

Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction.

Heestermans AA, van Werkum JW, Taubert D, Seesing TH, von Beckerath N, Hackeng CM, Schömig E, Verheugt FW, ten Berg JM. Heestermans AA, et al. Among authors: taubert d. Thromb Res. 2008;122(6):776-81. doi: 10.1016/j.thromres.2008.01.021. Epub 2008 May 1. Thromb Res. 2008. PMID: 18455217 No abstract available.

4

Cytochrome P-450 polymorphisms and response to clopidogrel.

Taubert D, Bouman HJ, van Werkum JW. Taubert D, et al. N Engl J Med. 2009 May 21;360(21):2249-50; author reply 2251. doi: 10.1056/NEJMc090391. N Engl J Med. 2009. PMID: 19458375 Free article. No abstract available.

5

Paraoxonase-1 is a major determinant of clopidogrel efficacy.

Bouman HJ, Schömig E, van Werkum JW, Velder J, Hackeng CM, Hirschhäuser C, Waldmann C, Schmalz HG, ten Berg JM, Taubert D. Bouman HJ, et al. Among authors: taubert d. Nat Med. 2011 Jan;17(1):110-6. doi: 10.1038/nm.2281. Epub 2010 Dec 19. Nat Med. 2011. PMID: 21170047

6

Clopidogrel resistance caused by a failure to metabolize clopidogrel into its metabolites.

Heestermans AA, van Werkum JW, Schömig E, ten Berg JM, Taubert D. Heestermans AA, et al. Among authors: taubert d. J Thromb Haemost. 2006 May;4(5):1143-5. doi: 10.1111/j.1538-7836.2006.01891.x. J Thromb Haemost. 2006. PMID: 16689772 Free article. No abstract available.

7

Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.

Bauer T, Bouman HJ, van Werkum JW, Ford NF, ten Berg JM, Taubert D. Bauer T, et al. Among authors: taubert d. BMJ. 2011 Aug 4;343:d4588. doi: 10.1136/bmj.d4588. BMJ. 2011. PMID: 21816733 Free PMC article. Review.

8

A patient with stent thrombosis, clopidogrel-resistance and failure to metabolize clopidogrel to its active metabolite.

von Beckerath N, Taubert D, Pogatsa-Murray G, Wieczorek A, Schömig E, Schömig A, Kastrati A. von Beckerath N, et al. Among authors: taubert d. Thromb Haemost. 2005 Apr;93(4):789-91. Thromb Haemost. 2005. PMID: 15841329 No abstract available.

9

Clopidogrel, CYP2C19, and a Black Box.

Ford NF, Taubert D. Ford NF, et al. Among authors: taubert d. J Clin Pharmacol. 2013 Mar;53(3):241-8. doi: 10.1002/jcph.17. Epub 2013 Feb 4. J Clin Pharmacol. 2013. PMID: 23381692

10

Pharmacokinetics of clopidogrel after administration of a high loading dose.

Taubert D, Kastrati A, Harlfinger S, Gorchakova O, Lazar A, von Beckerath N, Schömig A, Schömig E. Taubert D, et al. Thromb Haemost. 2004 Aug;92(2):311-6. doi: 10.1160/TH04-02-0105. Thromb Haemost. 2004. PMID: 15269827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters